These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6380393)

  • 41. The glucose sensor: the missing link in diabetes therapy.
    Pfeiffer EF
    Horm Metab Res Suppl; 1990; 24():154-64. PubMed ID: 2272621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of different control techniques for the regulation of blood glucose level in diabetic patients.
    Ibbini MS
    J Med Eng Technol; 2009; 33(8):656-62. PubMed ID: 19848860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Possibilities and risks of insulin pump therapy].
    Renner R; Lüddeke HJ
    Internist (Berl); 1990 Mar; 31(3):226-35. PubMed ID: 2187830
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparison of metabolic control between the continuous subcutaneous insulin infusion pump and augmented conventional treatment. Effects after 12 months].
    Goicolea Opacua I; Hernández Colau I; Cortázar Galarza A; Vázquez García JA
    Med Clin (Barc); 1987 Apr; 88(16):617-20. PubMed ID: 3298874
    [No Abstract]   [Full Text] [Related]  

  • 45. [Semiautomatic insulin injection equipment (pens)].
    Ganz K; Theintz G; Gerber P; Assal JP
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1228-9. PubMed ID: 2237052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beneficial effect of glycaemic improvement in non-ischaemic forms of diabetic retinopathy: a 3-year follow-up.
    Selam JL; Millet P; Zaluski S; Saeidi S; Mirouze J
    Diabet Med; 1986 Jan; 3(1):60-4. PubMed ID: 2951139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapeutic hyperinsulinism induced by the use of continuous insulin infusion pumps and the artificial pancreas in diabetic patients].
    Bergua M; Levy I; Casamitjana R; Figuerola D
    Med Clin (Barc); 1983 Sep; 81(6):243-5. PubMed ID: 6358714
    [No Abstract]   [Full Text] [Related]  

  • 48. The natural history of brittle diabetes.
    Williams G; Pickup JC
    Diabetes Res; 1988 Jan; 7(1):13-8. PubMed ID: 3042251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of diabetics using portable insulin pumps].
    Vavrinec J; Kopecký A; Zizkovský V; Lebl J; Sturmová M
    Cesk Pediatr; 1985 Dec; 40(12):701-4. PubMed ID: 4085018
    [No Abstract]   [Full Text] [Related]  

  • 50. [Multiple insulin injection therapy as intensive insulin therapy].
    Itoh H; Namba M; Kono N; Tarui S
    Nihon Rinsho; 1990 Dec; 48 Suppl():1015-21. PubMed ID: 2086862
    [No Abstract]   [Full Text] [Related]  

  • 51. [Insulin pump treatment of diabetic children and adolescents].
    Artavia-Loria E; Couprie C; Chaussain JL; Bougnères PF
    Ann Pediatr (Paris); 1986 Dec; 33(10):909-15. PubMed ID: 3827099
    [No Abstract]   [Full Text] [Related]  

  • 52. Continuous subcutaneous insulin infusion as a treatment option: a perspective after seven years of research applications.
    Pickup JC
    Diabet Med; 1984 May; 1(1):27-32. PubMed ID: 6242772
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparison of the development of retinopathy in treatment with the insulin pump and intensified conventional therapy].
    Bernsmeier H; Cicmir I; Koschinski T; Gries FA
    Fortschr Ophthalmol; 1986; 83(4):467-70. PubMed ID: 3770622
    [No Abstract]   [Full Text] [Related]  

  • 54. [Portable infusion pumps for insulin administration in type I diabetic patients].
    Wilke W; Hüttl I
    Z Arztl Fortbild (Jena); 1989; 83(9):449-53. PubMed ID: 2665333
    [No Abstract]   [Full Text] [Related]  

  • 55. Portable insulin infusion pumps as an alternative means of insulin delivery in type I diabetes. Report on 11 patients.
    Distiller LA
    S Afr Med J; 1983 Mar; 63(13):475-9. PubMed ID: 6340223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evolution of blood glucose control and retinopathy during long-term treatment of insulin-dependent diabetes mellitus with intraperitoneal infusion of insulin].
    Jaffiol C; Jacques-Apostol D; Renard E; Millet P; Compeyre S; Lauton D; Picot MC; Bringer J
    Bull Acad Natl Med; 1996 Jan; 180(1):177-91; discussion 191-4. PubMed ID: 8696875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin infusion therapy. Potential benefits and risks.
    Bonner RA
    Postgrad Med; 1985 May; 77(6):153-64. PubMed ID: 3921945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An artificial endocrine pancreas--problems awaiting solution for long-term clinical applications of a glucose sensor.
    Shichiri M; Fukushima H; Sakakida M; Kajiwara K; Hashiguchi Y
    Front Med Biol Eng; 1991; 3(4):283-92. PubMed ID: 1799562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diabetes and the insulin pump: functional results after 5 consecutive years of permanent use].
    Mirouze J; Rouault R; Misse P; Millet P; Bordat B; Selam JL; Boudet C
    Bull Soc Ophtalmol Fr; 1989 Mar; 89(3):437-40. PubMed ID: 2598391
    [No Abstract]   [Full Text] [Related]  

  • 60. [Continuous subcutaneous insulin infusion; the first decade].
    Doorenbos H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):91-3. PubMed ID: 3821988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.